Abstract Systolic function is often evaluated by measuring ejection fraction and its preservation is often assimilated with the lack of impairment of systolic left ventricular (LV) function. Considering the left ventricle as a muscular pump, we explored LV function during chronic hypertension independently of increased afterload conditions. Fourteen conscious and chronically instrumented pigs received continuous infusion of either angiotensin II (n = 8) or saline (n = 6) during 28 days. Hemodynamic recordings were regularly performed in the presence and 1 h after stopping angiotensin II infusion to evaluate intrinsic LV function. Throughout the protocol, the mean arterial pressure steadily increased by 55 ± 4 mmHg in angiotensin II-treated animals. There were no significant changes in stroke volume, LV fractional shortening or LV wall thickening, indicating the lack of alterations in LV ejection. In contrast, we observed maladaptive changes with (1) the lack of reduction in isovolumic contraction and relaxation durations with heart rate increases, (2) abnormally blunted isovolumic contraction and relaxation responses to dobutamine and (3) a linear correlation between isovolumic contraction and relaxation durations. None of these changes were observed in saline-infused animals. In conclusion, we provide evidence of impaired LV function with concomitant isovolumic contraction and relaxation abnormalities during chronic hypertension while ejection remains preserved and no sign of heart failure is present. The evaluation under unloaded conditions shows intrinsic LV abnormalities.
Introduction
Systolic function is often evaluated by measuring ejection fraction, and its preservation is often interpreted as an absence of impairment of systolic left ventricular (LV) function [15] . Usual description of LV function distinguishes systolic from diastolic alterations based on a classic hemodynamic model of the heart [36] . However, it has to be emphasized that the classical so-called diastole and systole are tightly coupled [14, 21] , and it is well known that concomitant alterations of systolic and diastolic ventricular function occur during ischemic heart disease [22, 26] . Moreover, several human studies have reported some alterations in parameters describing systolic function, e.g., mitral annular DTI velocity [2] or long axis systolic DTI velocity [33, 37] when ejection fraction was preserved. Most of these studies analyzed LV function as a hydraulic input-output system as opposed to a muscular pump perspective [7, 23, 38] .
In this setting and considering the heart as a muscular pump, we aimed at investigating LV function during chronic hypertension in a large mammal. Previous large animal hypertensive models used renal wrapping [13, 27] or angiotensin II delivered through implanted osmotic pumps [29, 30] . This hypertension was irreversible and the influence of increased afterload per se could not be easily distinguished from intrinsic LV alterations. Moreover, there is generally missing information about early phases of LV dysfunction development. Alternatively, we focused on the development of LV dysfunction during chronic hypertension in the absence of any signs of heart failure and investigated LV contraction, relaxation and filling independently of increased afterload condition. In the present study, hypertension was induced by continuously infusing angiotensin II during 4 weeks with external peristaltic pumps in chronically instrumented conscious pigs. During the protocol, hemodynamic status was regularly investigated and, at each scheduled recording, infusion of angiotensin II was stopped for an hour in order to allow arterial blood pressure to return to pre-treatment values. This novel approach allowed both the characterization of LV function during hypertension and the evaluation of the intrinsic LV properties under unloaded conditions, i.e., in the absence of angiotensin II infusion.
Methods
The experiments were conducted in accordance with the regulations concerning the use of animals in research.
Surgical instrumentation
Under anesthesia, 14 female pigs (20-30 kg) underwent left thoracotomy. Fluid-filled Tygon catheters were implanted in the proximal descending thoracic aorta, in the left atrium and in the pulmonary artery for the measurement of arterial blood pressure and angiotensin II infusion. A solid-state pressure transducer (P5A, Konigsberg Instruments, Pasadena, CA, USA) was introduced into LV. A flow probe (Transonic Systems Inc., Ithaca, NY, USA) was implanted around the aortic root. Piezoelectric crystals were implanted (1) on opposing LV anterior and posterior endocardial surfaces to measure LV internal diameter, and (2) on opposing LV endocardial and epicardial anterior free wall surfaces to measure wall thickness. All catheters and wires were exteriorized between the scapulae. Animals were sedated with diazepam (0.2-0.4 mg/kg iv) for postoperative care. Enrofloxacin (2 mg/kg/day, im) and long acting amoxicillin (15 mg/kg every 2 days, im) were administered for 10 days after surgery. Buprenorphine (0.3 mg sc) was administered for 5 days after surgery. The position of all catheters and crystals was confirmed at autopsy.
Hemodynamic measurements
All hemodynamic data were recorded (1 kHz), digitized and analyzed using HEM v4.2 software (Notocord Systems, Croissy sur Seine, France). Aortic and left atrial pressures were measured with P23XL pressure transducers (Becton-Dickinson, Franklin Lakes, NJ, USA). Cardiac output was measured using a T206 blood flow meter (Transonic Systems Inc., Ithaca, NY, USA). Left ventricular pressure was cross calibrated with the left atrial and aortic pressures. The change in LV pressure over time (dP/dt) was computed from the LV pressure signal. Percentage of wall thickening was defined as end-systolic minus end-diastolic thicknesses divided by end-diastolic thickness 9 100. The signal of LV wall thickness and LV internal diameter were suitable in 11 of the 14 instrumented pigs.
LV end-diastole was defined as the initiation of the upstroke of LV pressure tracing after atrial contraction and indicated by the initial increase in LV dP/dt. Aortic valve opening and closure were identified by crossing LV and aortic pressure waveforms. Furthermore, these determinations were confirmed by matching the waveforms with the aortic flow signal. The isovolumic contraction time was defined as the time interval between end diastole and aortic valve opening. The ejection time was defined as the time interval between aortic valve opening and closure. Mitral valve opening was identified by crossing LV and atrial pressure waveforms. The isovolumic relaxation period was defined as the period elapsed from aortic valve closure and mitral valve opening. The filling period was computed from the end of isovolumic relaxation to end diastole.
Mean ejection LV wall stress
Cylindrical wall stress was calculated as: stress = 1.36 [(LVP 9 ID)/2 h], where LVP is LV pressure, ID is internal diameter (short axis) and h is wall thickness. The integral of the systolic wall stress over time, so-called mean ejection wall stress, was calculated during the ejection period.
Isovolumic relaxation time constant
The time constant of isovolumic LV pressure (LVP) decay s was calculated using pressure data points during the isovolumic relaxation period and was computed using the logistic method [25, 31] :
where P A is an amplitude constant and P B is the pressure asymptote. The non-linear least squares problem was solved utilizing the Levenberg-Marquardt algorithm.
Protocol
The experiments were conducted 2-3 weeks after surgery when pigs were healthy and apyretic. All animals were studied in the conscious state staying in a sling and care was taken that at least two respiratory cycles were included in each recording. The first set of recordings was performed to obtain measurements at Day 0. Then, responses to dobutamine (10 lg/kg/min, 5 min) were evaluated. Thereafter, eight pigs received a continuous angiotensin II infusion (30 ng/kg/min) for 4 weeks using external peristaltic portable pumps. This dose was chosen on the basis of dose-response curves established in preliminary experiments (angiotensin II, 10-100 ng/kg/min iv). Hemodynamic data were regularly recorded at Days 3, 7, 14, 21 and 28. Each recording was performed in the presence and 1 h after stopping the angiotensin II infusion in order to minimize the impact of changes on loading conditions, i.e., to evaluate the intrinsic LV contractile properties. Dobutamine infusions were repeated at Day 28 in the absence of angiotensin II. Each animal served as its own control. In addition, six other pigs received saline infusion and served as matched controls.
Histology
Slices from the left ventricle were fixed in 4 % formalin and embedded in paraffin for histology. Thick paraffinembedded sections of 5 lm were stained with Sirius red for the visualization of collagen fibers. Sections were mounted in Eukitt and examined under a bright-field microscope. Interstitial fibrosis was quantified and expressed as a percentage of the field area (10 fields analyzed at 109 magnification).
Statistical analysis
All results are mean ± SEM. Statistical analysis was performed using one-way analyses of variance for repeated measures. When overall differences were detected, individual comparisons were performed by Student's t test for paired observations with Bonferroni's correction. A value of p \ 0.05 was considered statistically significant.
Results

Hemodynamic
Hemodynamic parameters in angiotensin II-and salinetreated pigs are shown in Tables 1 and 2 , respectively. The angiotensin II-treated animals did not develop any clinical signs of heart failure such as dyspnea, edema or ascitis.
In angiotensin II-treated animals, arterial blood pressure significantly increased during 4 weeks of angiotensin II infusion and this effect remained stable (Fig. 1a) , confirming the constant effectiveness of angiotensin II infusion. The rises in systolic, diastolic and mean blood pressures averaged 61 ± 3, 50 ± 3 and 54 ± 3 mmHg over 4 weeks, respectively. At Day 28, systolic, diastolic and mean arterial blood pressures reached 184 ± 5, 134 ± 3 and 158 ± 5 mmHg, respectively (Fig. 1b) .
In order to evaluate the intrinsic LV function independently of an increase in arterial blood pressure, angiotensin II infusion was stopped for 1 h during each recording. Values of systolic, diastolic and mean arterial pressure returned to Day 0 levels (122 ± 3 vs. 120 ± 3, 85 ± 4 vs. 82 ± 3 and 105 ± 3 vs. 101 ± 3 mmHg, respectively) ( Fig. 1c) . Calculation of mean ejection wall stress confirmed that the loading conditions were matched between Day 0 and Day 28 when the infusion of angiotensin II was stopped (247 ± 23 vs. 270 ± 39 g/cm 2 , respectively, p = NS).
Heart rate values measured at Day 28 either with or without angiotensin II were significantly increased versus Day 0 (93 ± 4 and 107 ± 8 vs. 80 ± 2 beats/min, respectively). None of these effects were observed in saline treated pigs.
Development of LV hypertrophy
Chronic infusion of angiotensin II induced a progressive and significant increase in LV end-diastolic wall thickness (Fig. 2a) . As compared to age and weight-matched control pigs (n = 6), LV to body weight ratio was significantly increased in angiotensin II-treated animals ( Fig. 2b) , indicating LV hypertrophy. Histological analysis also showed a clear increase in interstitial fibrosis (Fig. 2c) . Collagen content evaluated with Sirius red was increased from 6.2 ± 0.7 to 10.2 ± 1.2 % in saline-versus angiotensin IItreated animals (p \ 0.05).
Isovolumic relaxation alterations
We observed abnormal evolution of isovolumic relaxation over 4 weeks of angiotensin II infusion (Table 3) . Along with the increase in heart rate at Day 28, total cycle was significantly reduced by 22 % in the absence of angiotensin II. However, isovolumic relaxation time remained paradoxically unchanged between Day 0 and Day 28, i.e., the ratio of isovolumic relaxation to total systolic time was significantly increased by 21 %. That is, the time devoted to isovolumic relaxation during each minute increased by 36 % (8.0 ± 0.3 vs. 5.9 ± 0.1 s/min at Day 28 vs. Day 0, respectively). Similar alterations were observed in the presence of angiotensin II at Day 28 as compared to Day 0. Thus, regardless of the presence or absence of angiotensin II, the relative time of isovolumic relaxation was abnormally prolonged at Day 28. These changes were not observed in control pigs (Table 4) .
We further analyzed the isovolumic relaxation period by calculating the isovolumic time constant s. Paradoxically, s remained unchanged at Day 28 both in the presence and absence of angiotensin II as compared to Day 0 (17 ± 1 and 18 ± 1 vs. 17 ± 1 ms), i.e., isovolumic relaxation failed to accelerate with the increase in heart rate.
Importantly, as increasing heart rate differently influences the various phases of the cardiac cycle, we further analyzed the hemodynamic recordings at different levels of heart rate measured at Day 0 before any angiotensin II infusion. As shown in Fig. 3a , the physiological increase in heart rate in these pigs (before starting angiotensin II infusion, n = 8) induced significant decreases in isovolumic relaxation time, as opposed to the lack of decrease after 4 weeks of angiotensin II infusion.
Concerning dobutamine infusion, at Day 0, isovolumic relaxation time decreased by 18 % with the normal increase in triple product of heart rate, LV dP/dt max and maximal LV pressure. Interestingly, this response was significantly blunted after 4 weeks of angiotensin II infusion (-11 %) (Fig. 3b) . Saline-treated animals exhibited similar response between Day 0 and Day 28 (-16 and -17 %, respectively).
Preserved ejection
During 4 weeks of chronic angiotensin II infusion, stroke volume, LV fractional shortening and LV wall thickening were similar both in the presence and absence of angiotensin II as compared to Day 0 (Fig. 4 ). Concomitantly and due to the rise in heart rate, cardiac output increased at Day 28 as compared to Day 0 (3.5 ± 0.4 and 3.3 ± 0.5 L/min with or without angiotensin II at Day 28, respectively, vs. 2.7 ± 0.3 L/min at Day 0, p \ 0.05).
Altered isovolumic contraction
We next analyzed isovolumic contraction to determine whether it was altered along with isovolumic relaxation. We first focused on time intervals (Table 3) at Day 28 in the absence of angiotensin II as compared to Day 0, i.e., it was significantly increased by 30 % when related to cycle time. Thus, the time devoted to isovolumic contraction during each minute was significantly increased by 38 % (5.9 ± 0.3 vs. 4.3 ± 0.2 s/min at Day 28 and Day 0, respectively). These changes were not observed in control pigs (Table 4) . At Day 0 (before starting angiotensin II infusion), these parameters were also analyzed at different levels of heart rate. Isovolumic contraction time decreased when heart rate was rising (Fig. 5a ). This parameter (expressed as % of cycle) remained unchanged (8 ± 1, 8 ± 1 and 8 ± 1 % of cycle for heart rates at 80 ± 2, 93 ± 1 and 102 ± 1 beats/ min, respectively). This contrasts with the changes of these parameters observed after 4 weeks of angiotensin II infusion. Finally, we investigated isovolumic contraction using dobutamine infusion. At Day 0 (Fig. 5b) , isovolumic contraction time decreased by 45 %, while the triple product of heart rate, LV dP/dt max and maximal LV pressure increased. After 4 weeks of angiotensin II infusion (in the absence of angiotensin II), this response was significantly blunted (-27 %). This shows a maladaptive response to inotropic stimulation with a lack of reduction in isovolumic contraction time. Saline-treated animals exhibited similar response between Day 0 and Day 28 (-42 % and -44 %, respectively).
Diastolic filling alterations
In parallel to the maladaptive response of isovolumic contraction and relaxation, the absolute diastolic filling time was significantly reduced (Table 3) . Saline-treated pigs showed similar values between Day 0 and Day 28 (Table 4) .
Relationship between isovolumic contraction and relaxation As illustrated in Fig. 6a , there was a linear relationship between the isovolumic relaxation time values (% of cycle time) and corresponding times of isovolumic contraction (% of cycle time) either in the presence or the absence of angiotensin II. Values were measured at Days 0, 3, 7, 14, 21 and 28. This indicates that the development of alterations in isovolumic relaxation mirrored those of isovolumic contraction (Fig. 6b) . The timing of alterations did not differ between contraction and relaxation. For example, both isovolumic contraction time and isovolumic relaxation time (expressed as % of cycle) increased up to 8.9 ± 0.6 and 12.7 ± 0.4 % at Day 14 from 7.2 ± 0.3 and 9.8 ± 0.1 % at Day 0, respectively. 
Discussion
The present study demonstrates impaired left ventricular function in the presence of a preserved ejection in chronic hypertensive pigs as demonstrated by maladaptive changes in isovolumic contraction and relaxation, regardless of changes in loading conditions. These two periods were tightly coupled and simultaneously altered. Indeed, we observed (1) a paradoxical increase in relative durations of isovolumic contraction and relaxation concomitant with the increase in heart rate over 4 weeks of angiotensin II infusion, (2) both abnormal isovolumic contraction and relaxation responses to dobutamine and (3) a linear correlation between isovolumic contraction and relaxation durations. The link between contraction and relaxation has been previously described in intact animal and human studies investigating the effects of acute load changes, ischemic heart disease, pulmonary hypertension or systemic chronic hypertension [5, 6, 8, [18] [19] [20] [21] 37] . However, they did not distinguish between load influences and intrinsic LV changes nor analyze the consequences of stress conditions such as dobutamine.
In this study, we investigated our animals during chronic hypertension and did not observe any of the usual signs of heart failure. As previously described [9, 11, 17] , LV hypertrophy correlates with the impaired LV isovolumic relaxation and delayed mitral valve opening. In this pig model, isovolumic relaxation time remained unchanged despite the increase in heart rate observed over 4 weeks of angiotensin II infusion. This was accompanied by a reduced diastolic filling time. We also evaluated LV pressure decay during isovolumic relaxation by a mathematical model based on a logistic equation, yielding a constant s which shows a stable estimate of relaxation [25, 31] . At Day 28, despite the increase in heart rate, s was abnormally unchanged as compared to Day 0. This contrasts with the normal heart which accelerates LV relaxation at higher rates as shown by our results obtained at Day 0 at various levels of heart rate and by previous reports [4] . We further investigated isovolumic relaxation during dobutamine infusion and demonstrated again the inability of the heart to adequately adapt to stress.
We next focused on stroke volume, fractional shortening and LV wall-systolic thickening. All these parameters were unchanged and cardiac output was not reduced, indicating preserved ejection. However, none of these parameters specifically investigate the isovolumic phase. We therefore turned our attention towards the isovolumic contraction phase searching for alterations independent of ejection. In contrast to the normal heart, isovolumic contraction time remained unchanged. The ratio of isovolumic contraction to total systolic time was paradoxically and significantly increased after 4 weeks of angiotensin II infusion, i.e., the systolic isovolumic contraction failed to accelerate with the increase in heart rate. One could argue that increasing heart rate would differently influence the various phases of the cardiac cycle and, therefore, explain our results [16] . This is unlikely as the analysis of these time intervals with different levels of heart rate in basal conditions (at Day 0 before starting angiotensin II infusion) clearly shows Despite decreases in cycle time, isovolumic contraction and relaxation durations failed to reduce. Both phases were tightly coupled and changes in isovolumic contraction mirrored those of isovolumic relaxation opposite pattern. Moreover, in the presence of dobutamine, the isovolumic contraction time failed to adequately decrease. Again, this contrasts with the normal heart in which there is a linear relationship between this pre-ejection period and R-R interval [34] . In the present study, changes in the two LV isovolumic phases were simultaneous and tightly coupled. There was a linear correlation between isovolumic contraction and relaxation under normal and stress conditions with dobutamine. In accordance with the concept that the heart is a muscular pump rather than a hydraulic pump [3] , there was symmetry between isovolumic contraction and relaxation as illustrated in Fig. 6b . One could speculate that increased fibrosis and remodeling [1, 24] could partly explain these alterations but further investigations are needed.
Several limitations of the present study should be stressed. First, we did not specifically investigate the cellular mechanisms explaining the alteration in isovolumic contraction. Abnormalities in calcium handling and cell shortening may occur [10, 12, 28, 32] . Second, we did not perform echocardiographic studies to measure myocardial deformation and evaluate left ventricular asynchrony. One could speculate that inappropriate prolonged isovolumic contraction is linked to increased systolic asynchrony with nonuniform activation. This would induce exacerbated ventricular nonuniformity and diastolic asynchrony with altered isovolumic relaxation. Furthermore, isovolumic contraction and cross-bridge detachment during relaxation are energy-consuming processes. With this regard, increased isovolumic time and slow LV relaxation may further jeopardize LV function during the development of the disease and the reduction of myocardial energy reserve. This pig model of hypertension does not induce heart failure per se but we believe that it constitutes the basis for future studies and the development of new pharmacological strategies. Finally, it remains unknown whether our results are limited to our experimental setting or rather could be generalized. The evaluation of isovolumic contraction should be re-visited in other animal models and/or humans. The use of pressure volume catheters may have missed subtle alterations in isovolumic contraction as the parameters usually investigated with PV loop do not specifically explore this phase and studies in patients with conductance catheter report the use of low frequency of acquisition (250 Hz) which may reduce the sensitivity of the detection [35] .
In conclusion, we provide evidence of impaired LV function with isovolumic contraction and relaxation abnormalities during chronic hypertension while ejection remains preserved and no sign of heart failure is present.
The evaluation under unloaded conditions shows intrinsic LV abnormalities.
